Insider filing · TERN

Hongbo Lu bought $5.0M of Terns Pharmaceuticals (TERN)

Executed Sep 12 2024, disclosed Sep 17 2024, 5 days later, against a two-business-day limit.

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

HL Hongbo Lu Director profile →

Hongbo Lu (Director) filed 4 Form 4 reports in the trailing twelve months (3 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Zenas BioPharma, Inc. (ZBIO). Across 3 priced purchase filings, the average 21-session return was +1.6% from execution and +2.9% from disclosure (delay-adjusted; derived). The largest single filing was $1.5M of ZBIO (75,000 sh × $20.00, as filed), executed Mar 31.

TERN TERN TERN · 6 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→